Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.

Saved in:
Bibliographic Details
Title: Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.
Authors: Chodak, G W1 (AUTHOR), Vogelzang, N J (AUTHOR), Caplan, R J (AUTHOR), Soloway, M (AUTHOR), Smith, J A (AUTHOR)
Source: JAMA: Journal of the American Medical Association. 2/6/91, Vol. 265 Issue 5, p618-621. 4p.
Database: Academic Search Ultimate
Description
ISSN:00987484
DOI:10.1001/jama.265.5.618